Cladribine and guselkumab 200 mg drugs

This tender by Fakultní nemocnice Hradec Králové (University Hospital Hradec Králové) is for the supply of immunosuppressive agents containing cladribine and guselkumab 200 mg over a period until 2029 (Lot 1: cladribine until 12 Feb 2029, Lot 2: guselkumab until 7 Feb 2028). The procedure is an open tender with award based solely on lowest price (100% weight). The total estimated value is CZK 21,339,100 (approx. EUR 882,000). Bidders may submit for both lots. Electronic submission is required. The notice is a correction (update/add) of an earlier notice (394469-2026). No procurement documents beyond the notice were analyzed. Key concerns: short submission deadline (approx. 1 month), missing eligibility criteria and required documents, and inconsistency in EU funding flag (XML indicates no EU funds, structured data says EU-funded).